Skip to main content
SpringerLink
Log in

Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population

  • Original Research Article
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Background and Objective

Little evidence exists regarding the marginal decrease in health-related quality of life (HRQoL) in relation to the presence of hypertension among a Hispanic population based on US population-based research.

Method

This cross-sectional study used data from the 2014 to 2015 Medical Expenditure Panel Survey (MEPS). The target population was comprised of Hispanic community-dwelling residents with hypertension in the USA. The independent variable was the presence of hypertension. The dependent variable was HRQoL, which was measured using the Short Form-12 (SF-12) physical health composite scale (PCS) and mental health composite scale (MCS).

Results

A total of 13,933 members of the Hispanic population met the study inclusion criteria, and the estimated population size was 36,440,400 Hispanics. Among them, 82.9% did not have any hypertensive condition (n = 11,466), while 17.7% had some hypertensive condition (n = 2467). SF-12 PCS scores (95% CI) were 46.62 (45.68–47.57) in the Hispanic population with hypertension and 51.62 (51.1–52.14) in the Hispanic population without hypertension. SF-12 MCS scores (95% CI) were 52.67 (52.07–53.27) in patients without hypertension and 50.35 (49.45–51.26) in the Hispanic population with hypertensive conditions.

Conclusion

The presence of hypertension was associated with lower HRQoL in the Hispanic population. Based on our findings, we suggest that healthcare providers should monitor a hypertensive minority population for anxiety and mood disorders and recommend psychiatric assessment and treatment if appropriate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hayes DK, Denny CH, Keenan NL, Croft JB, Greenlund KJ. Health-related quality of life and hypertension status, awareness, treatment, and control: National health and nutrition examination survey, 2001–2004. J Hypertens. 2008;26(4):641–7. https://doi.org/10.1097/HJH.0b013e3282f3eb50.

    Article  CAS  PubMed  Google Scholar 

  2. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.

    Article  CAS  PubMed  Google Scholar 

  3. Gusmão JL, Mion D, Pierin AM. Health-related quality of life and blood pressure control in hypertensive patients with and without complications. Clinics (Sao Paulo). 2009;64(7):619–28.

    Article  PubMed Central  Google Scholar 

  4. Whelton PK, Carey RM, Aronow WS, Casey D, Collins KJ, Himmelfarb CD, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PNCA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–115.

    CAS  PubMed  Google Scholar 

  5. Hypertension Among Adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/data/databriefs/db133.htm#x2013;2012. Published October 31, 2013. Accessed 29 Jan 2019.

  6. Sánchez V, Cacari Stone L, Moffett ML, Nguyen P, Muhammad M, Bruna-Lewis S, Urias-Chauvin R. Process evaluation of a promotora de salud intervention for improving hypertension outcomes for latinos living in a rural US-mexico border region. Health Promot Pract. 2014;15(3):356–64.

    Article  PubMed  Google Scholar 

  7. López-Candales A. Importance of the hispanic heritage regarding diagnosis and management of hypertension. Postgrad Med. 2015;127(6):571–2.

    Article  PubMed  Google Scholar 

  8. Saleem F, Hassali MA, Shafie AA. A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in pakistan. Health Expect. 2014;17(3):388–95.

    Article  PubMed  Google Scholar 

  9. Zhang Y, Zhou Z, Gao J, Wang D, Zhang Q, Zhou Z, Su M, Li D. Health-related quality of life and its influencing factors for patients with hypertension: evidence from the urban and rural areas of shaanxi province, china. BMC Health Serv Res. 2016;16:277.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Trevisol DJ, Moreira LB, Fuchs FD, Fuchs SC. Health-related quality of life is worse in individuals with hypertension under drug treatment: results of population-based study. J Hum Hypertens. 2012;26(6):374–80.

    Article  CAS  PubMed  Google Scholar 

  11. Theodorou M, Kaitelidou D, Galanis P, Middleton N, Theodorou P, Stafylas P, et al. Quality of life measurement in patients with hypertension in Cyprus. Hellenic J Cardiol. 2011;52:407–15.

    PubMed  Google Scholar 

  12. Marianne A, Dan B-O. Hypertension and quality of life: the disease, the treatment or a combination of both. Psychol Health. 1996;11(5):685–95.

    Article  Google Scholar 

  13. Katsi V, Kallistratos MS, Kontoangelos K, et al. Arterial hypertension and health-related quality of life. Front Psychiatry. 2017;8:270. https://doi.org/10.3389/fpsyt.2017.00270 (Published 2017 Dec 4).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Fox C, Golden S, Anderson C, Bray G, Burke L, de Boer I, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777–803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Schmieder R, Ruilope L. Blood pressure control in patients with comorbidities. J Clin Hypertens (Greenwich Conn.). 2008;10:624–31.

    Article  Google Scholar 

  16. Mengden T, Ligges U, Mielke J, Bramlage P, Korzinek A, Sehnert W. Blood pressure control and cardiovascular risk in hypertensive patients with type 2 diabetes: the german T2Target registry. J Clin Hypertens. 2017;19(8):757–63. https://doi.org/10.1111/jch.13001.

    Article  CAS  Google Scholar 

  17. McLean DL, Simpson SH, McAlister FA, et al. Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies. Can J Cardiol. 2006;22:855–60.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Weycker D, Nichols GA, O’Keefe-Rosetti M, et al. Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens. 2007;20:599–607.

    Article  PubMed  Google Scholar 

  19. Chen G, McAlister FA, Walker RL, et al. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57:891–7.

    Article  CAS  PubMed  Google Scholar 

  20. Vega WA, Rodriguez MA, Gruskin E. Health disparities in the Latino population. Epidemiol Rev. 2009;31:99–112.

    Article  PubMed  Google Scholar 

  21. Meps.ahrq.gov [Medical Expenditure Panel Survey Background]. Agency for Healthcare Research and Quality. Available at http://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp. Accessed 31 Jan 2019.

  22. Cohen SB. Design strategies and innovations in the medical expenditure panel survey. Med Care. 2003;41(Suppl 7):III5–12.

    PubMed  Google Scholar 

  23. Cheak-Zamora N, Wyrwich K, McBride T. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Qual Life Res. 2009;18(6):727–35.

    Article  PubMed  Google Scholar 

  24. Jayasinghe UW, Harris MF, Taggart J, Christl B, Black DA. Gender differences in health-related quality of life of Australian chronically-ill adults: patient and physician characteristics do matter. Health Qual Life Outcomes. 2013;11:102.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2011;29:179–88.

    Article  CAS  PubMed  Google Scholar 

  26. Park C, Fang J, Hawkins NA, Wang G. Comorbidity status and annual total medical expenditures in US hypentensive aduts. Am J Prev Med. 2017;53(6S2):S172–81.

    Article  PubMed  PubMed Central  Google Scholar 

  27. González-Chica DA, Hill CL, Gill TK, Hay P, Haag D, Stocks N. Individual diseases or clustering of health conditions? Association between multiple chronic diseases and health-related quality of life in adults. Health Qual Life Outcomes. 2017;15(1):244.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Hajian-Tilaki K, Heidari B, Hajian-Tilaki A. Are gender differences in health-related quality of life attributable to sociodemographic characteristics and chronic disease conditions in elderly people? Int J Prev Med. 2017;8:95.

    PubMed  PubMed Central  Google Scholar 

  30. Robinson MR, Daniel LC, O’Hara EA, Szabo MM, Barakat LP. Insurance status as a sociodemographic risk factor for functional outcomes and health-related quality of life among youth with sickle cell disease. J Pediatr Hematol Oncol. 2014;36(1):51–6.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, et al. Quality of live and psychosocial factors in African American with Hypertensive Chronic Kidney Disease. Transl Res. 2012;159(1):4–11.

    Article  PubMed  Google Scholar 

  32. Burdine JN, Felix MR, Abel AL, Wiltraut CJ, Musselman YJ. The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res. 2000;35(4):885–904.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Elizabeth Riley and Jongwha Chang contributed equally to this work.

Authors and Affiliations

  1. Department of Pharmacy Practice, School of Pharmacy, University of Texas at El Paso, 500 W. University Ave, El Paso, TX, 79968, USA

    Elizabeth Riley & Jongwha Chang

  2. School of Pharmacy, Northeastern University, Boston, MA, USA

    Chanhyun Park

  3. School of Pharmacy, Shenandoah University, Winchester, VA, USA

    Sean Kim

  4. Korea Development Institute, Sejong, South Korea

    Inho Song

Authors
  1. Elizabeth Riley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jongwha Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chanhyun Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sean Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Inho Song
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jongwha Chang.

Ethics declarations

Conflict of interest

Elizabeth Riley, Chanhyun Park, Sean Kim, Inho Song, and Jongwha Chang declare no conflicts of interest.

Funding

This project was supported by a UTEP School of Pharmacy Seed Grant (226811487A).

Ethics approval

Institutional Review Board (IRB) approval was waived since MEPS is a publicly available de-identified dataset.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Riley, E., Chang, J., Park, C. et al. Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population. Clin Drug Investig 39, 899–908 (2019). https://doi.org/10.1007/s40261-019-00814-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-019-00814-4

Search

Navigation